BRD2 and neoplasm: Subsequently, to further link dose and scheduling to response, we developed a K-PD metastatic model of NAT using experimental data with multiple treatment periods (3, 7, 11, 14 days), doses (60 mg and 120 mg), and time of surgery after tumor implantation (day 34 or 38) (see S1 Table and methods for details).